Lepra: Klinik, Tanı ve Tedavi
References
Kundakci N, Erdem C. Leprosy: A great imitator.Clinics in dermatology. 2019;37(3):200-212. doi:10.1016/j.clindermatol.2019.01.002
Randhawa A, Kapila R, Schwartz RA. Leprosy: what is new. International journal of dermatology. 2022;61(6):733-738. doi:10.1111/ijd.15998
Virmond M, Grzybowski A, Virmond L. Leprosy: a glossary. Clinics in dermatology. 2015;33(1):8-18. doi:10.1016/j.clindermatol.2014.07.006
World Health Organization. Guidelines for the diagnosis, treatment and prevention of leprosy. World Health Organization. Regional Office for South-East Asia, 2018.
Ramos-e-Silva M, Ribeiro de Castro MC, Ochoa MT. Mycobacterial infections. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 5th ed. London: Elsevier; 2024. p. 1310–1333.
Maymone MBC, Laughter M, Venkatesh S, et al. Leprosy: Clinical aspects and diagnostic techniques. Journal of the American Academy of Dermatology. 2020;83(1):1-14. doi:10.1016/j.jaad.2019.12.080
Cruz RCDS, Bührer-Sékula S, Penna MLF, et al. Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. Anais brasileiros de dermatologia. 2017;92(6):761-773. doi:10.1590/abd1806-4841.20176724
Bala Murugan S, Mahendradas P, Dutta Majumder P, et al. Ocular leprosy: from bench to bedside. Current opinion in ophthalmology. 2020;31(6):514-520. doi:10.1097/ICU.0000000000000715
Lockwood DNJ. Chronic aspects of leprosy-neglected but important. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2019;113(12):813-817. doi:10.1093/trstmh/try131
Tomaselli PJ, Dos Santos DF, Dos Santos ACJ, et al. Primary neural leprosy: clinical, neurophysiological and pathological presentation and progression. Brain. 2022;145(4):1499-1506. doi:10.1093/brain/awab396
Gupta SK. Histoid leprosy: review of the literature. International journal of dermatology. 2015;54(11):1283-1288. doi:10.1111/ijd.12799
Khadilkar SV, Patil SB, Shetty VP. Neuropathies of leprosy. Journal of the neurological sciences. 2021;420:117288. doi:10.1016/j.jns.2020.117288
Ebenezer GJ, Scollard DM. Treatment and Evaluation Advances in Leprosy Neuropathy. Neurotherapeutics. 2021;18(4):2337-2350. doi:10.1007/s13311-021-01153-z
Sugawara-Mikami M, Tanigawa K, Kawashima A, et al. Pathogenicity and virulence of Mycobacterium leprae. Virulence. 2022;13(1):1985-2011. doi:10.1080/21505594.2022.2141987
Bhat RM, Prakash C. Leprosy: an overview of pathophysiology. Interdisciplinary perspectives on infectious diseases. 2012;2012:181089. doi:10.1155/2012/181089
Alemu Belachew W, Naafs B. Position statement: LEPROSY: Diagnosis, treatment and follow-up. Journal of the European Academy of Dermatology and Venereology. 2019;33(7):1205-1213. doi:10.1111/jdv.15569
Turner D, McGuinness SL, Leder K. Leprosy: diagnosis and management in a developed setting. Internal medicine journal. 2015;45(1):109-112. doi:10.1111/imj.12638
Mahajan VK. Slit-skin smear in leprosy: lest we forget it! Indian journal of leprosy. 2013;85(4):177-83.
Mungroo MR, Khan NA, Siddiqui R. Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options. Microbial pathogenesis. 2020;149:104475. doi:10.1016/j.micpath.2020.104475
Malhotra KP, Husain N. Laboratory perspectives for Leprosy: Diagnostic, prognostic and predictive tools. Indian journal of pathology & microbiology. 2022;65(Supplement):S300-S309. doi:10.4103/ijpm.ijpm_1083_21
Maymone MBC, Venkatesh S, Laughter M, et al. Leprosy: Treatment and management of complications. Journal of the American Academy of Dermatology. 2020;83(1):17-30. doi:10.1016/j.jaad.2019.10.138
Smith CS, Aerts A, Saunderson P, et al. Multidrug therapy for leprosy: a game changer on the path to elimination. The Lancet. Infectious diseases. 2017;17(9):e293-e297. doi:10.1016/S1473-3099(17)30418-8
Aubry A, Sammarco Rosa P, Chauffour A, et al. Drug resistance in leprosy: An update following 70years of chemotherapy. Infectious diseases now. 2022;52(5):243-251. doi:10.1016/j.idnow.2022.04.001
Kar HK, Gupta R. Treatment of leprosy. Clinics in dermatology. 2015;33(1):55-65. doi:10.1016/j.clindermatol.2014.07.007
Cogen AL, Lebas E, De Barros B, et al. Biologics in Leprosy: A Systematic Review and Case Report. The American journal of tropical medicine and hygiene. 2020;102(5):1131-1136. doi:10.4269/ajtmh.19-0616
Suresh B, Reshmi PR, Jaipal J, et al. Tofacitinib in Leprosy: A Novel Therapeutic Approach in Chronic Recalcitrant Type II Reactions. Cureus. 2024;16(11):e74694. Published 2024 Nov 28. doi:10.7759/cureus.74694
Rocha RH, Emerich PS, Diniz LM, et al. Lucio's phenomenon: exuberant case report and review of Brazilian cases. Anais brasileiros de dermatologia. 2016;91(5 suppl 1):60-63. doi:10.1590/abd1806-4841.20164370
Richardus JH, Oskam L. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis. Clinics in dermatology. 2015;33(1):19-25. doi:10.1016/j.clindermatol.2014.07.009
Schoenmakers A, Mieras L, Budiawan T, et al. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis. Research and reports in tropical medicine. 2020;11:97-117. Published 2020 Oct 15. doi:10.2147/RRTM.S190300
Steinmann P, Reed SG, Mirza F, et al. Innovative tools and approaches to end the transmission of Mycobacterium leprae. The Lancet. Infectious diseases. 2017;17(9):e298-e305. doi:10.1016/S1473-3099(17)30314-6
Wang L, Wang H, Yan L, et al. Single-Dose Rifapentine in Household Contacts of Patients with Leprosy. The New England journal of medicine. 2023;388(20):1843-1852. doi:10.1056/NEJMoa2205487